PerCP/Cyanine5.5 anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
HK1dot4_PerCPCy55_061909.jpg
C57BL/6 bone marrow cells stained with HK1.4 PerCP/Cyanine5.5
  • HK1dot4_PerCPCy55_061909.jpg
    C57BL/6 bone marrow cells stained with HK1.4 PerCP/Cyanine5.5
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability
128011 25 µg $141.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128012 100 µg $335.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  2. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  3. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  4. Awida Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  5. Asare-Bediako B, et al. 2022. Cells. 11:. PubMed
  6. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  7. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  8. van Elsas MJ, et al. 2023. J Immunother Cancer. 11:. PubMed
  9. Garabuczi É, et al. 2023. Front Immunol. 14:1139204. PubMed
  10. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  11. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  12. Solier S, et al. 2023. Nature. 617:386. PubMed
  13. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  14. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  15. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  16. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  17. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  18. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  19. Kang H, et al. 2022. Adv Mater. 34:e2106500. PubMed
  20. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  21. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  22. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  23. Schick J, et al. 2023. Elife. 12: . PubMed
  24. Tunali G, et al. 2023. J Clin Invest. :. PubMed
  25. Ballesteros I, et al. 2014. J Vis Exp. 94: 52031. PubMed
  26. Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
  27. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  28. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  29. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  30. Israelow B, et al. 2020. bioRxiv. . PubMed
  31. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  32. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  33. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  34. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  35. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  36. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  37. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  38. Yang Y, et al. 2020. Cell Death Discov. 0.293055556. PubMed
  39. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  40. Demars A, et al. 2021. PLoS Pathog. 17:e1009887. PubMed
  41. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  42. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  43. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  44. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  45. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  46. Han YH, et al. 2021. Science. 373:. PubMed
  47. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  48. McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
  49. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  50. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  51. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  52. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  53. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  54. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  55. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  56. Honarpisheh P, et al. 2020. J Neuroinflammation. 0.9625. PubMed
  57. Tanaka T, et al. 2015. J Immunol. 194:2004. PubMed
  58. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  59. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  60. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  61. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  62. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  63. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  64. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  65. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  66. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  67. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  68. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  69. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  70. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  71. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  72. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  73. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  74. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  75. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  76. Blriot C, et al. 2021. Immunity. :. PubMed
  77. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  78. Yang Y, et al. 2020. Cell Death Discov. 6:62. PubMed
  79. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  80. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  81. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  82. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  83. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  84. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  85. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  86. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  87. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  88. Klein O, et al. 2019. J Allergy Clin Immunol. 144:1074. PubMed
  89. Budai Z, et al. 2021. Cells. 10:. PubMed
  90. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
  91. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  92. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  93. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  94. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  95. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  96. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  97. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  98. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  99. Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
  100. Walsh CM, et al. 2019. Elife. 8:e48448. PubMed
  101. Foster G, et al. 2015. J Immunol. 195: 5380 - 5392. PubMed
  102. Yajjala V, et al. 2016. J Immunol. 196: 4196 - 4203. PubMed
  103. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  104. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  105. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  106. Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed
  107. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  108. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  109. Valdearcos M et al. 2017. Cell metabolism. 26(1):185-197 . PubMed
  110. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  111. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  112. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  113. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  114. Joshi JC, et al. 2020. Cell Rep. 30:4096. PubMed
  115. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  116. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  117. Ikezu S, et al. 2021. Mol Psychiatry. 26:1808. PubMed
  118. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  119. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  120. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  121. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  122. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  123. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  124. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
RRID
AB_1659242 (BioLegend Cat. No. 128011)
AB_1659242 (BioLegend Cat. No. 128012)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org
Go To Top Version: 2    Revision Date: 12/09/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account